These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26241819)

  • 21. Osteoporosis: what's new and on the horizon.
    Silva BC; Costa AG; Cusano NE; Bilezikian JP
    Clin Obstet Gynecol; 2013 Dec; 56(4):730-8. PubMed ID: 24036482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fracture Risk Assessment in Clinical Practice: Why Do It? What to Do It With?
    Chandran M
    J Clin Densitom; 2017; 20(3):274-279. PubMed ID: 28711299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fracture risk calculation tool enhances dual-energy X-ray absorptiometry scan referral pathway in cirrhosis patients.
    Nicoll R; Black A; Bailey L; Dundas P; McLeman L; Vijayan B; Fraser A; Mukhopadhya A
    Eur J Gastroenterol Hepatol; 2016 Jul; 28(7):757-61. PubMed ID: 27254536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fracture Risk Prediction Modeling and Statistics: What Should Clinical Researchers, Journal Reviewers, and Clinicians Know?
    Schousboe JT; Langsetmo L; Taylor BC; Ensrud KE
    J Clin Densitom; 2017; 20(3):280-290. PubMed ID: 28712982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of osteoporosis and assessment of fracture risk.
    Kanis JA
    Lancet; 2002 Jun; 359(9321):1929-36. PubMed ID: 12057569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of cortical porosity of the proximal femur improves identification of women with nonvertebral fragility fractures.
    Ahmed LA; Shigdel R; Joakimsen RM; Eldevik OP; Eriksen EF; Ghasem-Zadeh A; Bala Y; Zebaze R; Seeman E; Bjørnerem Å
    Osteoporos Int; 2015 Aug; 26(8):2137-46. PubMed ID: 25876879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual energy X-ray absorptiometry of the calcaneus: comparison with other techniques to assess bone density and value in predicting risk of spine fracture.
    Yamada M; Ito M; Hayashi K; Ohki M; Nakamura T
    AJR Am J Roentgenol; 1994 Dec; 163(6):1435-40. PubMed ID: 7992742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of bone quality in patients with diabetes mellitus.
    Jiang N; Xia W
    Osteoporos Int; 2018 Aug; 29(8):1721-1736. PubMed ID: 29736760
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density evaluation in osteoporosis: why yes and why not?
    Celi M; Rao C; Scialdoni A; Tempesta V; Gasbarra E; Pistillo P; Tarantino U
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S47-9. PubMed ID: 24046042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoporotic fractures, DXA, and fracture risk assessment: meeting future challenges in the Eastern Mediterranean Region.
    Baddoura R; Hoteit M; El-Hajj Fuleihan G
    J Clin Densitom; 2011; 14(4):384-94. PubMed ID: 21839659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Executive Summary of the 2015 ISCD Position Development Conference on Advanced Measures From DXA and QCT: Fracture Prediction Beyond BMD.
    Shepherd JA; Schousboe JT; Broy SB; Engelke K; Leslie WD
    J Clin Densitom; 2015; 18(3):274-86. PubMed ID: 26277847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Application of guidelines for secondary prevention of fracture and the FRAX index in patients with fragility fracture].
    Naranjo A; Ojeda-Bruno S; Francisco-Hernández F; Erausquin C; Rúa-Figueroa I; Rodríguez-Lozano C
    Med Clin (Barc); 2011 Mar; 136(7):290-2. PubMed ID: 21185575
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there an interaction between socioeconomic status and FRAX 10-year fracture probability determined with and without bone density measures? Data from the Geelong Osteoporosis Study of female cohort.
    Brennan SL; Quirk SE; Hosking SM; Kotowicz MA; Holloway KL; Moloney DJ; Dobbins AG; Pasco JA
    Calcif Tissue Int; 2015 Feb; 96(2):138-44. PubMed ID: 25578145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individualized fracture risk assessment: progresses and challenges.
    Nguyen TV; Center JR; Eisman JA
    Curr Opin Rheumatol; 2013 Jul; 25(4):532-41. PubMed ID: 23656708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct comparison of eight national FRAX® tools for fracture prediction and treatment qualification in Canadian women.
    Leslie WD; Brennan SL; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
    Arch Osteoporos; 2013; 8():145. PubMed ID: 23929269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Are bones in HIV-infected patient really fragile?].
    Biver E; Ciaffi L; Rizzoli R; Calmy A
    Rev Med Suisse; 2013 Jun; 9(390):1246-50. PubMed ID: 23821841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
    Rubin KH; Abrahamsen B; Friis-Holmberg T; Hjelmborg JV; Bech M; Hermann AP; Barkmann R; Glüer CC; Brixen K
    Bone; 2013 Sep; 56(1):16-22. PubMed ID: 23669650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of postmenopausal osteoporosis.
    Andreopoulou P; Bockman RS
    Annu Rev Med; 2015; 66():329-42. PubMed ID: 25386933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving Rural Bone Health and Minimizing Fracture Risk in West Virginia: Validation of the World Health Organization FRAX Assessment Tool as a Phone Survey for Osteoporosis Detection.
    Shuler FD; Scott K; Wilson-Byrne T; Morgan L; Olajide OB
    W V Med J; 2016; 112(3):84-8. PubMed ID: 27301160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of biochemical markers in the management of osteoporosis.
    Henriksen K; Christiansen C; Karsdal MA
    Climacteric; 2015; 18 Suppl 2():10-8. PubMed ID: 26507704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.